Passage BioPASG
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 30 institutions reported holding Passage Bio Inc. (PASG) in their 13F filings, down 1 from Q3 2025. 5 opened new positions and 7 sold out. The largest holders were Lynx1 Capital Management LP ($7.4M), Vestal Point Capital, LP ($3.6M) and Vanguard Group Inc. ($1.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Passage Bio Inc.
- CUSIP
- 702712209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2.2M |
| Exits | 7 | $1.2M |
All 13F filers, Q3 2025 → Q4 2025: 215,217 shares bought and 209,295 shares sold, net +5,922 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Lynx1 Capital Management LP | 1.49% | No change | 623,704 | $7.4M |
| Vestal Point Capital, LP | 0.13% | No change | 305,000 | $3.6M |
| Vanguard Group Inc. | 0.00% | Add +8.2% | 126,645 | $1.5M |
| Eversept Partners, LP | 0.08% | New | 126,230 | $1.5M |
| Renaissance Technologies | 0.00% | Add +8.2% | 109,089 | $1.3M |
| Erste Asset Management GmbH | 0.01% | Reduce -30.6% | 85,262 | $1.0M |
| Yiheng Capital Management, L.P. | 0.18% | New | 34,301 | $405K |
| Geode Capital Management, LLC | 0.00% | Add +15.1% | 31,397 | $371K |
| BlackRock, Inc. | 0.00% | Reduce -2.8% | 28,903 | $341K |
| Acadian Asset Management LLC | 0.00% | Reduce -5.4% | 24,196 | $284K |
| Citadel Advisors | 0.00% | Reduce -7.5% | 17,660 | $208K |
| Northern Trust Corp. | 0.00% | New | 14,217 | $168K |
| Quadrature Capital Ltd | 0.00% | New | 12,578 | $148K |
| Squarepoint Ops LLC | 0.00% | Reduce -54.0% | 10,799 | $127K |
| Fiduciary Trust Co | 0.00% | No change | 10,750 | $127K |
| Nano Cap New Millennium Growth Fund L P | 0.10% | — | 10,000 | $118K |
| Morgan Stanley | 0.00% | Add +1164.8% | 4,275 | $50K |
| UBS Group AG | 0.00% | Add +8382.4% | 1,442 | $17K |
| Rockefeller Capital Management L.P. | 0.00% | New | 500 | $6K |
| Barclays PLC | 0.00% | No change | 212 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 142 | $2K |
| Bank of America Corp. | 0.00% | No change | 28 | $331 |
| Osaic Holdings, Inc. | 0.00% | No change | 20 | $236 |
| Parallel Advisors, LLC | 0.00% | No change | 16 | $189 |
| JPMorgan Chase & Co. | 0.00% | No change | 15 | $177 |
| BNP Paribas Financial Markets | 0.00% | No change | 12 | $142 |
| LRI Investments, LLC | 0.00% | No change | 12 | $142 |
| Harbour Investments, Inc. | 0.00% | No change | 3 | $35 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| Tsfg, LLC | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is PASG's weight in each manager's 13F, not the share of Passage Bio Inc. the manager owns.